Sage Journals: Discover world-class research

Retricted access

Research article

First published 2022-02

Epitope Mapping of Rituximab Using HisMAP Method

Teizo Asano, Hiroyuki Suzuki, Mika K. Kaneko [...]

Monoclonal Antibodies in Immunodiagnosis & Immunotherapy

Retricted access

Other

First published 2008-3

Successful treatment of amegakaryocytic thrombocytopenia with anti-CD20 antibody (rituximab) in a patient with systemic lupus erythematosus

T Fukushima, L Dong, T Sakai [...]

Lupus

Open access

Research article

First published 2023-05

Complement system in Anti-CD20 mAb therapy for cancer: A mini-review

Yiwen Gao

International Journal of Immunopathology and Pharmacology

Free access

Review article

First published 2016-4

Obinutuzumab for relapsed or refractory indolent non-Hodgkin’s lymphomas

Ludovic Gabellier, Guillaume Cartron

Therapeutic Advances in Hematology

Open access

Research article

First published 2019-7

Refractory autoimmune haemolytic anaemia following allogenic haematopoietic stem cell transplantation: successful treatment of rituximab

Xiaofan Li, Jiafu Huang, Zhijuan Zhu [...]

Journal of International Medical Research

Open access

Research article

First published 2023-7

Health-economic benefits of anti-CD20 treatments in relapsing multiple sclerosis estimated using a treatment-sequence model

Ide Smets, Matthijs Versteegh, Simone Huygens [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Research article

First published 2018-8

Rituximab in multiple sclerosis: Frequency and clinical relevance of anti-drug antibodies

Nicky Dunn, Alexander Juto, Malin Ryner [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2004-10

Antilymphoma Effects of Anti-HLA-DR and CD20 Monoclonal Antibodies (Lym-1 and Rituximab) on Human Lymphoma Cells

Cathy Liu, Gerald DeNardo, Evan Tobin [...]

Cancer Biotherapy and Radiopharmaceuticals

Free access

Review article

First published 2015-8

Obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemia: overview and perspective

Carolyn J. Owen, Douglas A. Stewart

Therapeutic Advances in Hematology

Retricted access

Research article

First published 2020-10

Impact of DOTA-Chelators on the Antitumor Activity of 177 Lu-DOTA-Rituximab Preparations in Lymphoma Tumor-Bearing Mice

Wioletta Wojdowska, Urszula Karczmarczyk, Lajos Balog [...]

Cancer Biotherapy and Radiopharmaceuticals

Search results